Skip to main content Skip to main navigation menu Skip to site footer
logo Dermatology Reports

eISSN 2036-7406

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Early Access
  • Guidelines for Authors
  • Register
  • Login
  • Search
  • Contacts

Editor-in-Chief: Carlo Cota, Italy

1.0
Impact Factor 2025
1.5
CiteScore 2025
1.0
Impact Factor 2025
1.5
CiteScore 2025
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Metastatic basal cell carcinoma to the bone: a case of bone metastasis in uncommon sites

    Olga Nigro, Claudio Chini, Ilaria Gioia Angiola Marcon, Annamaria De Giorgi, Linda Bascialla, Elisa Gallerani, Alice Giaquinto, Diego De Palma, Maurizio Lombardo
    12-07-2022
    https://doi.org/10.4081/dr.2022.9267
    1143
    PDF: 540
    Supplementary Table: 256
    HTML: 26
  • Durable complete response in a patient with BRAF-mutated advanced melanoma with ocular and skin toxicities from BRAF/MEK targeted therapy after checkpoint inhibitor treatment: a case report

    Carlotta Bertolina, Marinella Bertolotti, Claudia Leporati, Antonina Maria De Angelis, Sara Delfanti, Luigi Cerbone, Marco Ghiglione, Federica Grosso
    17-06-2025
    https://doi.org/10.4081/dr.2025.10324
    636
    PDF: 362
    HTML: 35
  • 10 | LEBRIKIZUMAB PROVIDES CLINICALLY MEANINGFUL RESPONSE IN FACE AND HANDS IN ADULTS AND ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: ADHOPE 1 STUDY L. Stingeni1, C. Vestergaard2, J. Seneschal3|4, S. Weidinger5, A. Wollenberg6|7|8, A. Irvine9, H. Agell10, J. Valls Bancells10, V. Sapena10, D. Thaçi7 | 1Dermatology Section, Department of Medicine and Surgery, University of Perugia, Italy; 2Department of Dermatology and Venerology, Aarhus University Hospital, Aarhus, Denmark; 3Department of Dermatology, University of Bordeaux, Bordeaux, France; 4Department of Dermatology and Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hospital Saint-André, Bordeaux, France; 5Department of Dermatology and Allergy, University Hospital Schleswig-Holstein, Kiel, Germany; 6University Medical Center of Augsburg, Augsburg, Germany; 7Institute and Comprehensive Center for Inflammatory Medicine at the University of Lübeck, Lübeck, Germany; 8Department of Dermatology and Allergology, LMU Hospital, Munich, Germany; 9Department of Clinical Medicine, Trinity College Dublin, Dublin, Ireland; 10Almirall S.A., Barcelona, Spain

    Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica
    24-09-2026
    https://doi.org/10.4081/dr.2026.11077
    231
    PDF: 161
  • Acne exacerbation after tofacitinib treatment for alopecia areata

    Sawsan Alharthi, Mohammed G. Turkmani, Mohammed I. AlJasser
    01-01-2022
    https://doi.org/10.4081/dr.2022.9396
    2695
    PDF: 900
    HTML: 45
  • Apalutamide-induced ichthyosiform eruption

    Christian Ciolfi, Anna Lunardon, Fortunato Cassalia, Mauro Alaibac
    24-08-2023
    https://doi.org/10.4081/dr.2023.9734
    824
    PDF: 521
    HTML: 59
  • Real-world use of dimethyl fumarate in patients with plaque psoriasis: a Delphi-based expert consensus

    Martina Burlando, Elena Campione, Aldo Cuccia, Giovanna Malara, Luigi Naldi, Francesca Prignano, Leonardo Zichichi
    29-12-2022
    https://doi.org/10.4081/dr.2023.9613
    1850
    PDF: 571
    HTML: 103
  • Natural language processing of online support group postings reveals patients’ perspectives on strategies for managing psoriasis

    Karan Rajalingam, Phillip M. Johansen, Nicole J. Levin, Jerry Qi, Oge Marques
    11-09-2023
    https://doi.org/10.4081/dr.2023.9824
    1030
    PDF: 985
    HTML: 43
  • A microRNA focus on acne

    Sarah Gordon, Alison M. Layton, Sandra Fawcett, Kehinde Ross
    02-02-2024
    https://doi.org/10.4081/dr.2024.9902
    1177
    PDF: 763
    HTML: 75
  • Severe paradoxical generalized pustular psoriasis induced by adalimumab biosimilar successfully treated with brodalumab

    Angela Fico, Edoardo Mortato, Claudia Paganini, Marina Talamonti, Cosimo Di Raimondo, Dionisio Silvaggio, Luca Bianchi, Marco Galluzzo
    30-05-2025
    https://doi.org/10.4081/dr.2025.10414
    942
    PDF: 489
    HTML: 55
  • Lenvatinib-induced severe generalized erythematous rash in a patient with hepatocellular carcinoma

    Yukari Matsumoto, Takeshi Fukumoto, Wakako Takahashi, Chikako Nishigori
    29-12-2022
    https://doi.org/10.4081/dr.2023.9617
    901
    PDF: 469
    HTML: 52
  • Churg-Strauss syndrome and hemorragic vasculitis

    Rui Moreira Marques, Ana Rita Cabral, Antonio Monteiro, Pedro Henriques
    e49
    02-12-2011
    https://doi.org/10.4081/dr.2011.e49
    1632
    PDF: 816
    HTML: 1085
  • Hidradenitis suppurativa: state-of-the-art review and update

    Marco Virone, Elena Zappia, Alberto Di Caro, Davide Carlesimo, Nicoletta Bernardini, Giovanni Pellacani, Antonio Giovanni Richetta, Steven Paul Nisticò, Annunziata Dattola
    27-08-2025
    https://doi.org/10.4081/dr.2025.10328
    1439
    PDF: 913
    HTML: 29
  • Post-inflammatory hyperpigmentation after carbon dioxide laser: review of prevention and risk factors

    Alhanouf Bin Dakhil, Asem Shadid, Saad Altalhab
    19-05-2023
    https://doi.org/10.4081/dr.2023.9703
    6548
    PDF: 980
    APPENDIX 1: 171
    HTML: 231
  • Vitiligo: What’s old, what’s new

    Mariabeatrice Bertolani, Eleonora Rodighiero, Maria Beatrice de Felici del Giudice, Torello Lotti, Claudio Feliciani, Francesca Satolli
    15-09-2021
    https://doi.org/10.4081/dr.2021.9142
    2969
    PDF: 1208
    HTML: 236
  • 26 | CONCOMITANT THERAPY WITH IXEKIZUMAB PLUS TIRZEPATIDE IN ADULTS WITH PSORIATIC ARTHRITIS AND OVERWEIGHT OR OBESITY DEMONSTRATED SUPERIOR DISEASE CONTROL COMPARED TO IXEKIZUMAB ALONE: RESULTS FROM THE PH3B TOGETHER-PSA TRIAL E. Filippi1, J. F. Merola2, P. Mease3, A. Kivitz4, N. Sattar5, L. C. Coates6, C. E. Kartman7, P. Fischer7, L. Sun7, A. Cardoso7, M. C. Genovese7, A. Ogdie8 | 1Eli Lilly Italia S.p.A, Florence, Italy; 2Department of Dermatology and Department of Medicine, Division of Rheumatology, UT Southwestern Medical Center and O’Donnell School of Public Health, Dallas, TX, USA; 3Providence Swedish Medical Center, Seattle, WA, USA; 4Altoona Center for Clinical Research, Duncansville, PA, USA; 5School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK; 6Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK; 7Eli Lilly and Company, Indianapolis, IN, USA; 8Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA

    Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica
    24-09-2026
    https://doi.org/10.4081/dr.2026.11088
    147
    PDF: 60
  • A case of grade 3 squamous cell carcinoma successfully treated with methotrexate

    Giovanni Sarracco, Fabio Rinaldi, Francesco Cusano
    14-03-2024
    https://doi.org/10.4081/dr.2024.9647
    563
    PDF: 462
    HTML: 30
  • 30 | Sonidegib for nevoid basal cell carcinoma (Gorlin) syndrome and EADO stage IIb sporadic basal cell carcinomas: a phase II study (SIBLINGS trial) Sara Farinatti1|2, Giuseppe Agenziano3, Emi Dika4|5, Emanuela Passoni6, Ketty Peris7, Pietro Quaglino8, Paola Queirolo9, Massimiliano Scalvenzi10, Iris Zalaudek11, Luigi Lorini11, Cristina Gurizzan1, Monica Variolo1|2, Paolo Bossi*1|2, Carlo Resteghini*1|2 | 1Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milano; 2Department of Biomedical Sciences, Humanitas University, Rozzano MI; 3Unit of Dermatology, Luigi Vanvitelli University of Campania, Naples; 4Oncologic Dermatology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna; 5Department of Medical and Surgical Sciences, DIMEC, University of Bologna, Bologna; 6Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan; 7Institute of Dermatology, Catholic University of the Sacred Heart, Rome; Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome; 8Dermatologic Clinic, University of Turin Medical School, Turin; 9Medical Oncology Unit; 10Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples; 11Department of Dermatology and Venereology, University of Trieste, Ospedale Maggiore, Trieste, Italy. *Contributed equally.

    Italian Melanoma Intergroup
    11-12-2025
    https://doi.org/10.4081/dr.2025.10772
    503
  • Comparison between dutasteride and finasteride in hair regrowth and reversal of miniaturization in male and female androgenetic alopecia: a systematic review

    Almuntsrbellah Almudimeegh, Hanadi AlMutairi, Fatimah AlTassan, Yomna AlQuraishi, Khalid Nabil Nagshabandi
    12-04-2024
    https://doi.org/10.4081/dr.2024.9909
    10377
    PDF: 1835
    SUPPLEMENTARY MATERIAL: 316
    HTML: 247
  • Increase of integrin α6+p63+ cells after ultraviolet B irradiation in normal human keratinocytes

    Gyeong-hun Park, Seung-seog Han, Sung-eun Chang, Jee-ho Choi
    e2
    02-12-2009
    https://doi.org/10.4081/dr.2009.e2
    1252
    PDF: 639
    HTML: 788
  • Targeting JAK/STAT signaling: ruxolitinib cream in the management of concurrent vitiligo and discoid lupus erythematosus

    Andrea Bassi, Vincenzo Piccolo, Grazia Gallippi, Giuseppe Argenziano, Michela Magnano, Carlo Mazzatenta
    11-09-2025
    https://doi.org/10.4081/dr.2025.10458
    478
    PDF: 381
    HTML: 26
  • Effects of regular exercise on skin moisturizing function in adults

    Ryosuke Oizumi, Yoshie Sugimoto, Hiromi Aibara
    18-05-2023
    https://doi.org/10.4081/dr.2023.9711
    1138
    PDF: 566
    HTML: 38
  • 25 | EARLY AND MAINTAINED TREAT-TO-TARGET RESPONSE WITH IXEKIZUMAB UP TO 5 YEARS IN MODERATE-TO-SEVERE PSORIASIS: A POST-HOC ANALYSIS OF UNCOVER-3 E. Filippi1, A. Armstrong2, J. F. Merola3, M. Megna4, X. Man5, M. Honma6, J-M. Carrascosa7, R. Chughtai7, K. Fotiou8, S. Sabatino8, M. Ngantcha8, A. Pinter9 | 1Eli Lilly Italia S.p.A, Florence, Italy; 2University of California, Los Angeles, CA, USA; 3University of Texas Southwestern Medical Center, Dallas, TX, USA; 4University of Naples Federico II, Naples, Italy; 5Zhejiang University, Hangzhou, China; 6Asahikawa Medical University, Asahikawa, Japan; 7Hospital Germans Trias, Universitat Autònoma de Barcelona, Barcelona, Spain; 8Eli Lilly and Company, Indianapolis, IN, USA; 9University Hospital Frankfurt, Frankfurt, Germany

    Associazione Dermatologi-Venereologi Ospedalieri Italiani e della Sanità Pubblica
    24-09-2026
    https://doi.org/10.4081/dr.2026.11087
    132
    PDF: 45
  • A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks

    Luciano Ibba, Luigi Gargiulo, Giulia Pavia, Alessandra Narcisi, Antonio Costanzo, Mario Valenti
    06-06-2023
    https://doi.org/10.4081/dr.2023.9722
    869
    PDF: 494
    HTML: 27
  • Platelet-rich plasma for the treatment of scleroderma-associated ulcers: a single-center experience and literature review

    Alessandra Grazia Condorelli, Alessia Paganelli, Chiara Marraccini, Elena Ficarelli, Alfonso Motolese, Luca Contu, Alberico Motolese
    21-02-2024
    https://doi.org/10.4081/dr.2024.9878
    1136
    PDF: 582
    SUPPLEMENTARY MATERIAL: 188
    HTML: 56
  • Rate of growth of Merkel cell carcinoma: a unique photographic evidence

    Eleonora Bearzi, Simona Sola, Carlotta Defferrari, Stefano Chiodi, Nicola Di Meo, Cesare Massone
    25-07-2025
    https://doi.org/10.4081/dr.2025.10457
    651
    PDF: 398
    HTML: 30
26 - 50 of 59 items << < 1 2 3 > >> 

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a Scientific paper
  • How to write a Review article
  • Article Processing Charge
  • Crediti ECM (Italian Authors)

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to Review
  • Thanks to Reviewers

Categories

    • Newsletter
    • Original Articles
    • Reviews
    • Case Reports

indexing

INDEXING
  • PubMed
  • PubMed Central
  • Scopus
  • DOAJ
  • ESCI
  • Google Scholar
  • OpenAlex
  • Web of Science
  • Analytics

dermatopathology

Dermatopathology

Dermatology Reports

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

 

https://godisnjak.pf.unibl.org/

https://revistascientificas.us.es/

pISSN: 2036-7392
eISSN: 2036-7406

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185
This journal is published by PAGEPress® srl (Pavia, Italy), which is the data controller for all personal data processed through this platform. For full details on how your data is collected, used and protected, please read our Privacy Policy.